资讯
Amgen 称药物组合可将侵袭性肺癌患者死亡风险降低 58%
原标题: Amgen 称药物组合可将侵袭性肺癌患者死亡风险降低 58%
📋总体概括
A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.
⚡关键信息
- ▸A drug from Amgen could give patients with an aggressive for
📰 相关资讯（与本文相关的其他资讯）
本文由本站自动聚合，以下为原始来源：前往 CNBC 能源新闻 阅读全文 →